LDOS Stock Analysis: Leidos Holdings | NYSE
Information Technology Services | NYSE, USA | Market Cap: 18.006m USD | 12M Return: -21.3% | US5253271028 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 202M
EPS Trend: 96.1%
Qual. Beats: 2
Rev. Trend: 97.4%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Leidos Holdings is a US-based provider of technology, engineering, and scientific services primarily to US federal agencies and allied foreign governments, with additional commercial customers. Founded in 1969 and headquartered in Reston, Virginia, the company operates through four reporting segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems.
The business model centers on long-term government contracts, including competitive and sole-source task orders, under which Leidos supplies software, systems integration, data analytics, and physical security equipment such as airport baggage scanners. A meaningful share of the workforce holds US security clearances, which functions as a structural barrier to entry in federal IT and defense services.
Leidos is grouped within the IT consulting and government services peer set, alongside contractors such as SAIC, Booz Allen Hamilton, and CACI. Key customers include the Department of Defense, the US intelligence community, federal civilian agencies, and state and local governments, with international work concentrated in allied defense, border security, and aviation markets.
- Pentagon spending growth accelerates National Security segment revenue
- Defense Enclave Services award expands operating margin and backlog
- Federal budget shutdown threats delay government contract timing
| Net Income: 1.39b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 3.49 > 1.0 |
| NWC/Revenue: 11.49% < 20% (prev 10.75%; Δ 0.74% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.30b > Net Income 1.39b |
| Net Debt (6.38b) to EBITDA (2.32b): 2.74 < 3 |
| Current Ratio: 1.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.0m) vs 12m ago -2.31% < -2% |
| Gross Margin: 17.42% > 18% (prev 17.56%; Δ -0.14% > 0.5%) |
| Asset Turnover: 120.9% > 50% (prev 125.9%; Δ -5.00% > 0%) |
| Interest Coverage Ratio: 9.06 > 6 (EBIT TTM 2.02b / Interest Expense TTM 223.0m) |
| A: 0.13 (Total Current Assets 5.25b - Total Current Liabilities 3.22b) / Total Assets 15.6b |
| B: 0.33 (Retained Earnings 5.22b / Total Assets 15.6b) |
| C: 0.14 (EBIT TTM 2.02b / Avg Total Assets 14.6b) |
| D: 0.51 (Book Value of Equity 5.28b / Total Liabilities 10.3b) |
| Altman-Z'' = 3.41 = A |
| DSRI: 0.98 (Receivables 2.97b/2.92b, Revenue 17.6b/17.1b) |
| GMI: 1.01 (GM 17.56% / 17.42%) |
| AQI: 1.07 (AQ_t 0.58 / AQ_t-1 0.54) |
| SGI: 1.03 (Revenue 17.6b / 17.1b) |
| TATA: -0.06 (NI 1.39b - CFO 2.30b) / TA 15.6b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of August 24, 2026, the stock is trading at USD 141.39 with a total of 669,653 shares traded. Over the past week, the price has changed by -1.70%, over one month by +28.15%, over three months by +10.75% and over the past year by -21.33%.
Current recommended Stop Loss: 136.10 (which is 3.7% or 1.2 ATR below the current price).
Leidos Holdings has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy LDOS.
- StrongBuy: 8
- Buy: 2
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 156.6 | 10.8% |
P/E Trailing = 13.2852
P/E Forward = 11.7647
P/S = 1.0211
P/B = 3.3784
P/EG = 2.4573
Revenue TTM = 17.6b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 2.32b USD
Long Term Debt = 6.01b USD (from longTermDebt, last quarter)
Short Term Debt = 22.0m USD (from shortTermDebt, last quarter)
Debt = 7.12b USD (from shortLongTermDebtTotal, last quarter) + Leases 547.0m
Net Debt = 6.38b USD (calculated: Debt 7.12b - CCE 748.0m)
Enterprise Value = 24.4b USD (18.0b + Debt 7.12b - CCE 748.0m)
Interest Coverage Ratio = 9.06 (Ebit TTM 2.02b / Interest Expense TTM 223.0m)
EV/FCF = 11.27x (Enterprise Value 24.4b / FCF TTM 2.16b)
FCF Yield = 8.87% (FCF TTM 2.16b / Enterprise Value 24.4b)
FCF Margin = 12.27% (FCF TTM 2.16b / Revenue TTM 17.6b)
Net Margin = 7.86% (Net Income TTM 1.39b / Revenue TTM 17.6b)
Gross Margin = 17.42% ((Revenue TTM 17.6b - Cost of Revenue TTM 14.6b) / Revenue TTM)
Gross Margin QoQ = 17.92% (prev 17.30%)
Tobins Q-Ratio = 1.56 (Enterprise Value 24.4b / Total Assets 15.6b)
Interest Expense / Debt = 3.13% (Interest Expense 223.0m / Debt 7.12b)
Taxrate = 11.31% (202.2m / 1.79b)
NOPAT = 1.79b (EBIT 2.02b * (1 - 11.31%))
Current Ratio = 1.63 (Total Current Assets 5.25b / Total Current Liabilities 3.22b)
Debt / Equity = 1.35 (Debt 7.12b / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = 2.74 (Net Debt 6.38b / EBITDA 2.32b)
Debt / FCF = 2.95 (Net Debt 6.38b / FCF TTM 2.16b)
Total Stockholder Equity = 5.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.50% (Net Income 1.39b / Total Assets 15.6b)
RoE = 27.55% (Net Income TTM 1.39b / Total Stockholder Equity 5.03b)
RoCE = 18.31% (EBIT 2.02b / Capital Employed (Equity 5.03b + L.T.Debt 6.01b))
RoIC = 15.34% (NOPAT 1.79b / Invested Capital 11.7b)
WACC = 6.35% (E(18.0b)/V(25.1b) * Re(7.76%) + D(7.12b)/V(25.1b) * Rd(3.13%) * (1-Tc(0.11)))
Discount Rate = 7.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.31 | Cagr: -3.31%
[DCF] Terminal Value 77.97% ; FCFF base≈1.86b ; Y1≈2.13b ; Y5≈3.14b
[DCF] Fair Price = 325.2 (EV 47.2b - Net Debt 6.38b = Equity 40.8b / Shares 125.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.06 | EPS CAGR: 23.47% | SUE: 1.38 | # QB: 2
Revenue Correlation: 97.40 | Revenue CAGR: 5.58% | SUE: 1.20 | # QB: 2
EPS current Quarter (2026-09-30): EPS=3.05 | Chg30d=-3.89% | Revisions=-50% | Analysts=14
EPS current Year (2026-12-31): EPS=12.40 | Chg30d=+0.40% | Revisions=+73% | GrowthEPS=+3.4% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=12.78 | Chg30d=-2.52% | Revisions=-18% | GrowthEPS=+3.1% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +4% (up=12, down=11)